Filtered By:
Countries: Turkey Health
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 90618 results found since Jan 2013.
Potential drug-drug interactions in University Hospital Medical Intensive Care Unit patients in Turkey
CONCLUSIONS: Use of frequently interacting drugs in the treatment of critically MICU patients may lead to potential drug-drug interactions and adverse reactions. Daily monitoring and updating of drug therapy can improve patient's quality of life by preventing or reducing potential drug-drug interactions.PMID:34859876 | DOI:10.26355/eurrev_202111_27264
Source: European Review for Medical and Pharmacological Sciences - December 3, 2021 Category: Drugs & Pharmacology Authors: M Jafarova Demirkapu S Pinar Kara Source Type: research
Evaluation of the effect of hyperchloremia on the prognosis and mortality of medical intensive care patients: a single-center study
DISCUSSION: Mortality in MICU patients were found to increase in association with higher Cl levels at admission, presence of cancer disease, and higher pCO2 levels. In addition, it should not be ignored that there may be an important relationship between renal failure and hyperchloremia in MICU patients.PMID:36422489 | DOI:10.55730/1300-0144.5510
Source: Turkish Journal of Medical Sciences - November 24, 2022 Category: General Medicine Authors: Habip Y ılmaz Ba şak Çakır Güney Source Type: research
Real-world patient-level cost-effectiveness analysis of omalizumab in patients with severe allergic asthma treated in four major medical centers in Turkey
Conclusion. Whereas most economic evaluations are based on aggregate data, this independent cost-effectiveness analysis using prospective real-world patient-level data suggests that omalizumab in combination with standard-of-care is cost-effective for severe asthma from the Turkish public payer perspective.PMID:37129881 | DOI:10.1080/13696998.2023.2209417
Source: Journal of Medical Economics - May 2, 2023 Category: Health Management Authors: Deniz Tugay Mehmet Top Ömür Aydin Sevim Bavbek Ebru Damado ğlu Ferda Öner Erkekol Ilkay Koca Kalkan A Fuat Kalyoncu G ül Karakaya I Kivilcim O ğuzülgen Haluk T ürktaş Ivo Abraham Source Type: research
Awareness and obscurity: demystifying genomic profiling in real-world practice for the members of the Turkish Society of Medical Oncology (TSMO)
CONCLUSIONS: Several informational difficulties must be resolved in order to have early personalized therapy as the standard treatment. We need accessible, comprehensive, and regularly updated databases to compare genetic profiling and its therapeutic implications. We also need to continue educating patients and physicians.PMID:37203840 | DOI:10.26355/eurrev_202305_32323
Source: European Review for Medical and Pharmacological Sciences - May 19, 2023 Category: Drugs & Pharmacology Authors: E Bayram B Sahin Source Type: research
